chairman Donald Trump Threatened to impose 200% tariff on the pharmaceuticals imported in the US on Tuesday “very soon.”

Trump said during a cabinet meeting, “They are going to be tariffs at a very high rate like 200%.”

But he suggested that those levy would not apply immediately, saying that he “will give people about a year, and a year”

“We will give them a certain time to get our work together,” Trump said.

The President has repeatedly threatened and then changed the syllabus on tariff proposals, so there is no guarantee that he will set the drug tariff at that rate. Pharmaceutical stocks were largely unchanged after Trump’s comments.

This is Trump’s most important comment on pharmaceutical-specific tariffs since April, when his administration launched the so-called section 232 investigation on those products. This legal authority allows the Commerce Secretary to investigate the impact of import on national security.

Those employed tariffs gave a long -awaited blow to pharmaceutical companies, many of which are near. pushed back And warned that levy can increase the costs, deitter Investment In the US and disrupting the supply chain of the drug, patients put at risk. The industry is already navigating the decline from Trump Drug price policiesThose who argue that drug manufacturers argue that their lower lines and their ability to invest in research and development are threatened.

Trump has said that tariff drug companies will encourage companies to transfer manufacturing operations in the US Ellie lily, Johnson & Johnson, Abbi And others are already investing more money in America, when domestic drug manufacturing has dramatically shrunk in the last few decades.